gefitinib has been researched along with daidzein in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (daidzein) | Trials (daidzein) | Recent Studies (post-2010) (daidzein) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,885 | 136 | 753 |
| Protein | Taxonomy | gefitinib (IC50) | daidzein (IC50) |
|---|---|---|---|
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 91.26 | |
| Estrogen receptor | Homo sapiens (human) | 2.97 | |
| Aldehyde dehydrogenase, mitochondrial | Homo sapiens (human) | 9 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 7.3 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.45 | |
| Estrogen receptor beta | Homo sapiens (human) | 1.6568 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YC; Chen, MC; Chen, RJ; Huang, CY; Kuo, CH; Kuo, WW; Mhone, TG; Shih, TC; Wang, TF; Yeh, CM | 1 |
1 other study(ies) available for gefitinib and daidzein
| Article | Year |
|---|---|
Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Isoflavones; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2022 |